Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1052

1.

Antihypertensive polytherapy in Australia: prevalence of inappropriate combinations, 2013-2018.

Falster MO, Buckley NA, Brieger D, Pearson SA.

J Hypertens. 2020 Feb 19. doi: 10.1097/HJH.0000000000002408. [Epub ahead of print]

PMID:
32084043
2.

Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners.

Luckett T, Newton-John T, Phillips J, Holliday S, Giannitrapani K, Powell-Davies G, Lovell M, Liauw W, Rowett D, Pearson SA, Raymond B, Heneka N, Lorenz K.

BMJ Open. 2020 Feb 17;10(2):e034363. doi: 10.1136/bmjopen-2019-034363.

3.

Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation.

Hsu B, Falster MO, Schaffer AL, Pearson S, Jorm L, Brieger DB.

Med J Aust. 2020 Feb 17. doi: 10.5694/mja2.50507. [Epub ahead of print] No abstract available.

PMID:
32067236
4.

Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study.

de Oliveira Costa J, Schaffer AL, Medland NA, Litchfield M, Narayan SW, Guy R, McManus H, Pearson SA.

AIDS Patient Care STDS. 2020 Feb;34(2):81-91. doi: 10.1089/apc.2019.0278.

PMID:
32049558
5.

Autophagy regulates functional differentiation of mammary epithelial cells.

Elswood J, Pearson SJ, Payne HR, Barhoumi R, Rijnkels M, W Porter W.

Autophagy. 2020 Feb 5:1-19. doi: 10.1080/15548627.2020.1720427. [Epub ahead of print]

PMID:
31983267
6.

Mobile Real-Time Grasshopper Detection and Data Aggregation Framework.

Chudzik P, Mitchell A, Alkaseem M, Wu Y, Fang S, Hudaib T, Pearson S, Al-Diri B.

Sci Rep. 2020 Jan 24;10(1):1150. doi: 10.1038/s41598-020-57674-8.

7.

The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).

Albertson TE, Chenoweth JA, Pearson SJ, Murin S.

Expert Opin Pharmacother. 2020 Feb;21(2):213-231. doi: 10.1080/14656566.2019.1701656.

PMID:
31955671
8.

The Sensor Technology and Rehabilitative Timing (START) Protocol: A Randomized Controlled Trial for the Rehabilitation of Mild Traumatic Brain Injury.

Parrington L, Jehu DA, Fino PC, Stuart S, Wilhelm J, Pettigrew N, Murchison CF, El-Gohary M, VanDerwalker J, Pearson S, Hullar T, Chesnutt JC, Peterka RJ, Horak FB, King LA.

Phys Ther. 2020 Jan 17. pii: pzaa007. doi: 10.1093/ptj/pzaa007. [Epub ahead of print]

PMID:
31951263
9.

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.

Parker WAE, Schulte C, Barwari T, Phoenix F, Pearson SM, Mayr M, Grant PJ, Storey RF, Ajjan RA.

Cardiovasc Diabetol. 2020 Jan 7;19(1):3. doi: 10.1186/s12933-019-0981-3.

10.

Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.

Blagden SP, Billingham L, Brown LC, Buckland SW, Cooper AM, Ellis S, Fisher W, Hughes H, Keatley DA, Maignen FM, Morozov A, Navaie W, Pearson S, Shaaban A, Wydenbach K, Kearns PR; Experimental Cancer Medicine Centres (ECMC) CID trials working group.

Br J Cancer. 2020 Feb;122(4):473-482. doi: 10.1038/s41416-019-0653-9. Epub 2020 Jan 6. Review.

PMID:
31907370
11.

The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.

Agboola F, Atlas SJ, Touchette DR, Fazioli K, Pearson SD.

J Manag Care Spec Pharm. 2020 Jan;26(1):16-20. doi: 10.18553/jmcp.2020.26.1.16.

12.

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Iveson T, Boyd KA, Kerr RS, Robles-Zurita J, Saunders MP, Briggs AH, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan H, Paul J.

Health Technol Assess. 2019 Dec;23(64):1-88. doi: 10.3310/hta23640.

13.

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date.

Pearson S, Kietsiriroje N, Ajjan RA.

Diabetes Metab Syndr Obes. 2019 Dec 2;12:2515-2529. doi: 10.2147/DMSO.S229802. eCollection 2019. Review.

14.

Breath-based non-invasive diagnosis of Alzheimer's disease: a pilot study.

Tiele A, Wicaksono A, Daulton E, Ifeachor E, Eyre V, Clarke S, Timings L, Pearson S, Covington JA, Li X.

J Breath Res. 2020 Feb 14;14(2):026003. doi: 10.1088/1752-7163/ab6016.

PMID:
31816609
15.

Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation.

Schaffer AL, Falster MO, Brieger D, Jorm LR, Wilson A, Hay M, Leeb K, Pearson S, Nasis A.

J Am Heart Assoc. 2019 Dec 17;8(24):e014287. doi: 10.1161/JAHA.119.014287. Epub 2019 Dec 4.

16.

The Effectiveness and Value of Treatments for Spinal Muscular Atrophy.

Pearson SD, Thokala P, Stevenson M, Rind D.

J Manag Care Spec Pharm. 2019 Dec;25(12):1300-1306. doi: 10.18553/jmcp.2019.25.12.1300.

17.

Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress.

Pearson SJ, Elswood J, Barhoumi R, Ming-Whitfield B, Rijnkels M, Porter WW.

Breast Cancer Res. 2019 Nov 27;21(1):125. doi: 10.1186/s13058-019-1207-z.

18.

Evolving targets for sedation during mechanical ventilation.

Pearson SD, Patel BK.

Curr Opin Crit Care. 2020 Feb;26(1):47-52. doi: 10.1097/MCC.0000000000000687.

PMID:
31764193
19.

Value assessment and heterogeneity: another side to the story.

Pearson SD.

Am J Manag Care. 2019 Nov;25(11):542-543.

20.

AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells.

Pearson S, Blance R, Somervaille TCP, Whetton AD, Pierce A.

Hemasphere. 2019 Jun 4;3(3):e233. doi: 10.1097/HS9.0000000000000233. eCollection 2019 Jun.

21.

Effectiveness of Methenamine for UTI Prevention in Older Adults.

Snellings MS, Linnebur SA, Pearson SM, Wallace JI, Saseen JJ, Fixen DR.

Ann Pharmacother. 2019 Nov 6:1060028019886308. doi: 10.1177/1060028019886308. [Epub ahead of print]

PMID:
31694390
22.

Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016).

Tang M, Schaffer A, Kiely BE, Daniels B, Simes RJ, Lee CK, Pearson SA.

Br J Cancer. 2019 Nov;121(11):904-911. doi: 10.1038/s41416-019-0612-5. Epub 2019 Nov 1.

PMID:
31673103
23.

Physicians' attitudes towards accelerated access to medicines.

Pace J, Kerridge I, Pearson S, Lipworth W.

Health Econ Policy Law. 2019 Oct 31:1-16. doi: 10.1017/S1744133119000288. [Epub ahead of print]

PMID:
31668160
24.

Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.

Pearson S, Guo B, Pierce A, Azadbakht N, Brazzatti JA, Patassini S, Mulero-Navarro S, Meyer S, Flotho C, Gelb BD, Whetton AD.

J Proteome Res. 2020 Jan 3;19(1):194-203. doi: 10.1021/acs.jproteome.9b00495. Epub 2019 Nov 12.

PMID:
31657576
25.

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.

Bruno C, Pearson SA, Daniels B, Buckley NA, Schaffer A, Zoega H.

BMJ Qual Saf. 2019 Oct 22. pii: bmjqs-2019-009897. doi: 10.1136/bmjqs-2019-009897. [Epub ahead of print]

26.

Reactive and eccentric strength contribute to stiffness regulation during maximum velocity sprinting in team sport athletes and highly trained sprinters.

Douglas J, Pearson S, Ross A, McGuigan M.

J Sports Sci. 2020 Jan;38(1):29-37. doi: 10.1080/02640414.2019.1678363. Epub 2019 Oct 19.

PMID:
31631783
27.

Prescription opioid dispensing in Australian children and adolescents: a national population-based study.

Bell J, Paget SP, Nielsen TC, Buckley NA, Collins J, Pearson SA, Nassar N.

Lancet Child Adolesc Health. 2019 Dec;3(12):881-888. doi: 10.1016/S2352-4642(19)30329-3. Epub 2019 Oct 8.

PMID:
31604614
28.
29.

Codeine use and harms in Australia: evaluating the effects of re-scheduling.

Cairns R, Schaffer AL, Brown JA, Pearson SA, Buckley NA.

Addiction. 2020 Mar;115(3):451-459. doi: 10.1111/add.14798. Epub 2019 Nov 19.

PMID:
31577369
30.

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit.

Pearson SD, Segel C, Cole A, Henshall C, Towse A.

J Comp Eff Res. 2019 Oct;8(13):1045-1054. doi: 10.2217/cer-2019-0094. Epub 2019 Sep 27.

31.

Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.

Pearson SE, Taylor J, Patel P, Baguley DM.

Int J Audiol. 2019 Nov;58(11):685-695. doi: 10.1080/14992027.2019.1660918. Epub 2019 Sep 23.

PMID:
31545660
32.

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia.

Schaffer AL, Buckley NA, Cairns R, Pearson S.

JAMA Netw Open. 2019 Sep 4;2(9):e1911590. doi: 10.1001/jamanetworkopen.2019.11590.

33.

"Some sort of fantasy land": A qualitative investigation of appropriate prescribing in cancer care.

Ghinea N, Wiersma M, Kerridge I, Olver I, Pearson S, Day R, Liauw W, Lipworth W.

J Eval Clin Pract. 2019 Sep 12. doi: 10.1111/jep.13278. [Epub ahead of print]

PMID:
31512353
34.

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015).

Daniels B, Kiely BE, Tang M, Tervonen H, Pearson SA.

BMC Cancer. 2019 Sep 11;19(1):909. doi: 10.1186/s12885-019-6126-y.

35.

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.

Challapalli A, Pearson S, Mitra AV, Coe M, Thomson A, Elliott T, Kirkbride P, Pickering L, Kirk H, Foulstone E, Evans H, Bravo A, Bahl AK.

J Int Med Res. 2019 Oct;47(10):4664-4672. doi: 10.1177/0300060519863546. Epub 2019 Sep 10. No abstract available.

36.

Relationships Between Dry-land Resistance Training and Swim Start Performance and Effects of Such Training on the Swim Start: A Systematic Review.

Thng S, Pearson S, Keogh JWL.

Sports Med. 2019 Dec;49(12):1957-1973. doi: 10.1007/s40279-019-01174-x. Review. Erratum in: Sports Med. 2019 Oct 3;:.

PMID:
31493205
37.

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, Veenstra D, Whittington MD, Ollendorf DA.

Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.

38.

Physeal-Sparing Transosseous-Equivalent Arthroscopic Rotator Cuff Repair.

Caldwell PE 3rd, Heisinger AJ, Pearson SE.

Arthrosc Tech. 2019 Jun 6;8(7):e663-e668. doi: 10.1016/j.eats.2019.02.012. eCollection 2019 Jul.

39.

Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults.

Chen Y, Kirk MD, Stuart R, Cheng AC, Pearson SA, Hayen A, Banks E, Liu B.

PLoS One. 2019 Aug 29;14(8):e0221480. doi: 10.1371/journal.pone.0221480. eCollection 2019.

40.

Patterns of immediate breast reconstruction in New South Wales, Australia: a population-based study.

Feng Y, Flitcroft K, van Leeuwen MT, Elshaug AG, Spillane A, Pearson SA.

ANZ J Surg. 2019 Oct;89(10):1230-1235. doi: 10.1111/ans.15381. Epub 2019 Aug 16.

41.

Utilisation of teratogenic medicines before and during pregnancy in Australian women.

Raichand S, Pearson SA, Zoega H, Buckley NA, Havard A.

Aust N Z J Obstet Gynaecol. 2019 Aug 9. doi: 10.1111/ajo.13044. [Epub ahead of print]

PMID:
31397495
42.

Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data.

Peacock A, Chiu V, Leung J, Dobbins T, Larney S, Gisev N, Pearson SA, Degenhardt L.

BMJ Open. 2019 Aug 5;9(8):e030605. doi: 10.1136/bmjopen-2019-030605.

43.

Optimal Melatonin Dose in Older Adults: A Clinical Review of the Literature.

Pierce M, Linnebur SA, Pearson SM, Fixen DR.

Sr Care Pharm. 2019 Jul 1;34(7):419-431. doi: 10.4140/TCP.n.2019.419.. Review.

PMID:
31383052
44.

Double diabetes: A distinct high-risk group?

Kietsiriroje N, Pearson S, Campbell M, Ariƫns RAS, Ajjan RA.

Diabetes Obes Metab. 2019 Dec;21(12):2609-2618. doi: 10.1111/dom.13848. Epub 2019 Aug 19. Review.

PMID:
31373146
45.

Maternal Mortality due to Eclampsia in Khyber Pakhtunkhwa: Identifying Underlying Risk Factors, and Care-seeking Behaviours.

Mir AM, Pearson S, Shaikh S, Khan M, Masud I, Hussain S.

J Pak Med Assoc. 2019 Jul;69(7):934-938.

46.

Why the Coming Debate Over the QALY and Disability Will be Different.

Pearson SD.

J Law Med Ethics. 2019 Jun;47(2):304-307. doi: 10.1177/1073110519857286. No abstract available.

PMID:
31298099
47.

Polypharmacy among older Australians, 2006-2017: a population-based study.

Page AT, Falster MO, Litchfield M, Pearson SA, Etherton-Beer C.

Med J Aust. 2019 Jul;211(2):71-75. doi: 10.5694/mja2.50244. Epub 2019 Jun 20.

PMID:
31219179
48.

New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?

Pearson SD, Ollendorf DA, Chapman RH.

Value Health. 2019 Jun;22(6):656-660. doi: 10.1016/j.jval.2019.01.012. Epub 2019 May 17.

PMID:
31198182
49.

Exercise trials for blood pressure control: keeping it REAL.

Pearson SA, Buckley N, Stamatakis E.

Br J Sports Med. 2019 Dec;53(23):1443-1444. doi: 10.1136/bjsports-2019-100787. Epub 2019 Jun 7. No abstract available.

PMID:
31175109
50.

Exploring variation in low-value care: a multilevel modelling study.

Badgery-Parker T, Feng Y, Pearson SA, Levesque JF, Dunn S, Elshaug AG.

BMC Health Serv Res. 2019 May 30;19(1):345. doi: 10.1186/s12913-019-4159-1.

Supplemental Content

Loading ...
Support Center